MedTrace Logo

Decisional Quality for Patients With Coronary Artery Disease

NCT02145481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 677

Last updated 2018-12-04

No results posted yet for this study

Summary

The objective of the DeQCAD study is to measure the quality of the decision-making process for patients with coronary artery disease (CAD) and Acute Coronary Syndrome (ACS) who are making treatment decisions. In particular, this study is seeking to answer: a) How informed are patients about their treatment choices, b) are patients participating in the decision-making process as much as they would like to, and c) do the treatment decisions made match patients' preferences?

Conditions

Interventions

BEHAVIORAL

Decision Aid

Decision aid describing treatment choices for patients with coronary artery disease.

BEHAVIORAL

CAD Education

Education for patients with coronary artery disease

Sponsors & Collaborators

  • University of Missouri, Kansas City

    collaborator OTHER

  • Mid America Heart Institute

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • R. Adams Dudley, MD, MBA · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2018-08-15
Completion
2018-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02145481 on ClinicalTrials.gov